Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$0.89
NASDAQLPCN
Open
$0.89
Change
$0.01 (0.58%)
Day's Range
$0.87 - $0.91
52-Week Range
$0.71 - $1.89
Volume
72.3K
Market Cap
$78.8M